Quick Answer
Revolution Medicines, Inc. reported Total Assets of $2.35 billion for fiscal year 2025.
Revolution Medicines, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $2.35B | -8.0% |
| 2024 | $2.56B | +24.1% |
| 2023 | $2.06B | +153.9% |
| 2022 | $811.93M | +10.0% |
| 2021 | $737.99M | +30.1% |
| 2020 | $567.40M | +157.3% |
| 2019 | $220.53M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.25B | +27.7% | -7.3% |
| June 30, 2025 | $2.43B | +34.3% | +2.7% |
| March 31, 2025 | $2.37B | +23.9% | -7.5% |
| December 31, 2024 | $2.56B | +24.1% | +45.1% |
| September 30, 2024 | $1.76B | +79.1% | -2.5% |
| June 30, 2024 | $1.81B | +68.4% | -5.2% |
| March 31, 2024 | $1.91B | +77.8% | -7.4% |
| December 31, 2023 | $2.06B | +153.9% | +109.5% |
- Revolution Medicines, Inc. showed a decrease of -8.0% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Revolution Medicines, Inc.’s total assets has grown by 967.7% (from $220.53 million to $2.35 billion).
- The most recent figure is from Revolution Medicines, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: